COVID-19 in ART: Perception and Experience

Assessing the Perception and the Personal Experience of the COVID19 Pandemic Among Infertile Couples Undergoing Assisted Reproductive Treatment (ART)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04456010

Acronym

COVAPEX

Enrollment

600

Registered

2020-07-02

Start date

2020-06-01

Completion date

2020-07-30

Last updated

2020-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ART, COVID19, Fertility Issues

Keywords

fertility, risk perception, emotional experience

Brief summary

Non-urgent medical care, such as fertility treatments, has been massively postponed during the past weeks due to the COVID19 pandemic. The lockdown and the closure of IVF centers might cause anxiety and depression among infertile couples, who are already exposed to the distressing experience of infertility and for whom the wait for a baby already appears unending. Few data are available regarding the impact of SARS-CoV-2 on pregnant women and foetus, or on fertility. This study aims to assess the views of infertile couple regarding the potential risks of COVID during their fertility treatment and their personal experience of the COVID pandemic and their expectation for further treatment .

Interventions

OTHERQuestionnaire

Eligible patients will be selected from our electronical database and invited via email to participate.

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

\- Men and women who had a fertility treatment prescribed during the past 9 months in our Fertility department

Exclusion criteria

* Patient attending for a fertility preservation * Patient attending for a preimplantation genetic testing (PGT-M or PGT-SR) * Patient not fluent in French

Design outcomes

Primary

Measure	Time frame	Description
Personal experience of the COVID19 pandemic and the discontinuation of their fertility treatment pandemic and the discontinuation	1 day	Personal experience of the COVID19 pandemic and the discontinuation of their fertility treatment, via a survey

Secondary

Measure	Time frame	Description
Risk assessment	1 day	. Risk assessment by the patient, via a survey, regarding SARS-CoV-2 during a fertility treatment or during pregnancy. Perception of the risks linked to SARS-CoV-2 during their fertility treatment or during a pregnancy
Patients'expectations regarding the management of an abrupt closure of the fertility center	1 day	Patients'expectations regarding the management of an abrupt closure of the fertility center, via a survey

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026